In order to obtain this action we must pay 142,34$ right now, In this post we are going to talk about the listed company Neurocrine Biosciences Inc, its leaders are Bill Wilson (Vice President-Information Technology & Operations), Dimitri E. Grigoriadis (Chief Research Officer), Eiry W. Roberts (Chief Medical Officer), Kevin Charles Gorman (Chief Executive Officer & Director), Matthew C. Abernethy (Chief Financial Officer), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 141,69$ moving between 140,51$ and 142,86$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.